FDA Warns Providers Not to Use Any NECC Products

The FDA has warned healthcare providers to cease use of any products manufactured at the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.


Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

The alert comes after the FDA determined that two additional drugs, triamcinolone acetonide and cardioplegic solution, from the compounding center may be contaminated. A federal/state investigation is ongoing regarding contaminated steroid injections that led to an outbreak of meningitis, claiming 15 lives.

More Articles on Patient Safety:

7 Strategies for Collaboration and Safety in the Operating Room

8 Points of Survival for Surgery Centers After ACOs

Study: Simulation Training Needed to Boost Patient Safety, Operative Performance

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Patient Safety Tools & Resources Database

Featured Webinars

Featured Whitepapers

Featured Podcast